Krystal Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
CEOKrish S. Krishnan
CEOKrish S. Krishnan
Employees275
Employees275
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2016
Founded2016
Employees275
Employees275
KRYS Key Statistics
Market cap4.02B
Market cap4.02B
Price-Earnings ratio33.10
Price-Earnings ratio33.10
Dividend yield—
Dividend yield—
Average volume459.09K
Average volume459.09K
High today$143.44
High today$143.44
Low today$136.44
Low today$136.44
Open price$138.46
Open price$138.46
Volume279.21K
Volume279.21K
52 Week high$219.34
52 Week high$219.34
52 Week low$122.80
52 Week low$122.80
KRYS News
TipRanks 1d
Krystal Biotech initiated with a Buy at Clear StreetClear Street analyst Bill Maughan initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $190 price target Krystal’s first commercial product, Vyjuv...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.